First Time Loading...

Centessa Pharmaceuticals PLC
NASDAQ:CNTA

Watchlist Manager
Centessa Pharmaceuticals PLC Logo
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Watchlist
Price: 8.87 USD -0.89% Market Closed
Updated: May 18, 2024

Centessa Pharmaceuticals PLC
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Centessa Pharmaceuticals PLC
Interest Income Expense Peer Comparison

Comparables:
EXAI
AUTL
BCYC
IMCR
GNS

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Interest Income Expense
$570k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Interest Income Expense
£12.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Interest Income Expense
-$29m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Interest Income Expense
$13.4m
CAGR 3-Years
N/A
CAGR 5-Years
125%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Interest Income Expense
-£344k
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Interest Income Expense
-£10.1m
CAGR 3-Years
N/A
CAGR 5-Years
-102%
CAGR 10-Years
-20%

See Also

What is Centessa Pharmaceuticals PLC's Interest Income Expense?
Interest Income Expense
570k USD

Based on the financial report for Dec 31, 2023, Centessa Pharmaceuticals PLC's Interest Income Expense amounts to 570k USD.